Monday, October 17, 2016

Minims Saline





1. Name Of The Medicinal Product



Minims Saline (Astromins, Ultra Saline Minims).


2. Qualitative And Quantitative Composition



A clear, colourless liquid containing Sodium Chloride PhEur 0.9% w/v.



3. Pharmaceutical Form



Single-use, sterile eye drops.



4. Clinical Particulars



4.1 Therapeutic Indications



As a topical ocular irrigating solution.



4.2 Posology And Method Of Administration



Adults (including the elderly) and Children:



Adequate solution should be used to irrigate the eye.



4.3 Contraindications



None.



4.4 Special Warnings And Precautions For Use



None.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None known.



4.6 Pregnancy And Lactation



Not applicable.



4.7 Effects On Ability To Drive And Use Machines



None known.



4.8 Undesirable Effects



None known.



4.9 Overdose



Not applicable.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Minims Saline is an isotonic solution of sodium chloride used for irrigation of the eye. There are no pharmacodynamic properties of relevance for this product.



5.2 Pharmacokinetic Properties



There are no pharmacokinetic properties which are applicable for this product.



5.3 Preclinical Safety Data



There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Purified Water



6.2 Incompatibilities



None known.



6.3 Shelf Life



15 months.



6.4 Special Precautions For Storage



Store below 25°C. Do not freeze. Protect from light.



6.5 Nature And Contents Of Container



A sealed conical shaped container fitted with a twist and pull off cap overwrapped in an individual polypropylene/paper pouch. Each Minims unit contains approximately 0.5ml of solution.



6.6 Special Precautions For Disposal And Other Handling



Discard each unit after a single use.



7. Marketing Authorisation Holder



Chauvin Pharmaceuticals Ltd



106 London Road



Kingston-upon-Thames



Surrey



KT2 6TN



8. Marketing Authorisation Number(S)



PL 0033/5017R



9. Date Of First Authorisation/Renewal Of The Authorisation



Date of first Authorisation: 19.5.87.



10. Date Of Revision Of The Text



June 1997



November 2002





No comments:

Post a Comment